- Home
- STXS vs XBIT Comparison
STXS vs XBIT Comparison
Compare STXS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STXS
- XBIT
- Stock Information
- Founded
- STXS 1990
- XBIT 2005
- Country
- STXS United States
- XBIT United States
- Employees
- STXS N/A
- XBIT N/A
- Industry
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- XBIT Pharmaceuticals and Biotechnology
- Sector
- STXS Health Care
- XBIT Health Care
- Exchange
- STXS Nasdaq
- XBIT Nasdaq
- Market Cap
- STXS 151.3M
- XBIT 89.6M
- IPO Year
- STXS 2004
- XBIT 2015
- Fundamental
- Price
- STXS $2.20
- XBIT $3.18
- Analyst Decision
- STXS
- XBIT
- Analyst Count
- STXS 0
- XBIT 0
- Target Price
- STXS N/A
- XBIT N/A
- AVG Volume (30 Days)
- STXS 288.7K
- XBIT 187.9K
- Earning Date
- STXS 08-11-2025
- XBIT 08-11-2025
- Dividend Yield
- STXS N/A
- XBIT N/A
- EPS Growth
- STXS N/A
- XBIT N/A
- EPS
- STXS N/A
- XBIT N/A
- Revenue
- STXS $27,510,000.00
- XBIT N/A
- Revenue This Year
- STXS $25.90
- XBIT N/A
- Revenue Next Year
- STXS $60.57
- XBIT N/A
- P/E Ratio
- STXS N/A
- XBIT N/A
- Revenue Growth
- STXS 1.50
- XBIT N/A
- 52 Week Low
- STXS $1.54
- XBIT $2.50
- 52 Week High
- STXS $2.72
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- STXS 52.17
- XBIT 63.47
- Support Level
- STXS $2.08
- XBIT $2.58
- Resistance Level
- STXS $2.36
- XBIT $3.32
- Average True Range (ATR)
- STXS 0.12
- XBIT 0.17
- MACD
- STXS -0.01
- XBIT 0.07
- Stochastic Oscillator
- STXS 55.56
- XBIT 82.93
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.